Following are the Major Driving Factors for Drug Discovery Services Industry:

Increasing research and development investments made by pharmaceutical and biopharmaceutical companies, growing R&D pipeline for pharmaceutical drugs influencing the growth in demand for outsourcing the analytical testing services, global initiatives made for research on…

Below are the vital factors responsible to bring revolution in the global pharmaceutical drug delivery industry:

1. Advancements in drug delivery technologies offer several benefits, such as ease of use, convenience, and patient compliance. These technologies aim to improve the overall experience of drug administration for patients.

2.…

Research Methodologies Followed:

Primary Research:

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess the prospects of the market. Various primary sources from both the supply and demand sides of the…

Overview of This Study:

This study involved four major activities in estimating the size of brain monitoring market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research.

The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data…

Global Growth Driving Factors:

The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Growth in this market is attributed to the growing prevalence of sinusitis, the rapidly growing geriatric population, favorable reimbursements for ENT procedures in developed countries, the…

Overview of This Study:

This market research study involves the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global human microbiome market.

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to…

The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Global Growth Driving Factors:

Growth in this market driven by the rising incidence of skin diseases and increasing awareness of aesthetic procedures. The expansion of healthcare infrastructure in developing regions is…

Major Growth Drivers:

The rising geriatric population and subsequent growth in the prevalence of neurological & cardiovascular disorders drives growth in the electroceuticals market, rising government support & funding for neurological disorders, and the increasing investments and funding for research on CRM devices are among the other factors. Emerging economies such as China and Japan are providing lucrative opportunities for the players operating in the…

Drivers: Increasing incidence of cancer and HIV/AIDS

Diagnostic/ Prognostic information on clinical research on cancer and HIV/ AIDS can be derived using flow cytometry. Besides this, flow cytometry has applications such as the enumeration of helper T-cells (CD4 cells) in HIV infections, determining DNA content, and profiling tumor cells in breast cancer, lymphoma, leukemia, and other malignancies.

The fast-growing burden of cancer has led to a rise in the demand for…

Overview of This Study:

This study involved four major activities for estimating the current size of the global respiratory care devices market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate…

Global Growth Driving Factors:

Factors such as the increasing adoption of EHR solutions, government initiatives and incentive programs, rising focus on reducing the abuse of controlled substances, increasing focus on reducing medical errors, and the need to curtail the escalating healthcare costs are driving the growth of the e-prescribing market. Additionally, the onset of the COVID-19 pandemic has accelerated the use of telemedicine modules and telehealth consultations. This…

Global Growth Driving Factors:

Drug delivery is the method or process of administration of a pharmaceutical drug to safely attain its desired therapeutic effect. Advancements in drug delivery technologies offer several benefits, such as ease of use, convenience, and patient compliance. Drug developers are focusing on suitable delivery and packaging options for increasing the efficiency of drugs and proposing improved patient compliance.

Pharmaceutical and…

Global Growth Driving Factors:

The incidence of hospital-acquired infections due to improper probe reprocessing has been drastically increasing in the recent past. This has led to an emerging awareness about infection control, especially with regards to ultrasound probes, which is one of the major drivers of the global market. Simultaneously, the rising prevalence of chronic diseases also leads to more ultrasound imaging procedures being performed, which in turn increases the…

Drivers: Increasing incidence and prevalence of neurological disorders

The global incidence and prevalence of neurological disorders, such as dementia, epilepsy, Parkinson's disease, Huntington's disease, headache disorders, multiple sclerosis, neuro infections, stroke, and cerebral palsy, have increased significantly over the years. Brain disorders, which include a combination of developmental, psychiatric, and neurodegenerative diseases, are a growing cause of morbidity…

Global Growth Driving Factors:

Expansion of healthcare infrastructure across the emerging markets, growing adoption of novel neurovascular devices, and greater research in the field of neurovascular therapies are high growth prospects for the neurovascular devices/ interventional neurology market during the forecast period.

Major Surge in Revenue Growth:

The global neurovascular devices market in terms of revenue was estimated to be worth $2.5 billion in…

Opportunity: Rising government funding to develop advanced medical treatments

The major focus of government bodies on improving healthcare infrastructure, including critical care infrastructure, in their respective healthcare systems is expected to support the growth of allied markets, including the electrosurgery market.

Government bodies in many developed countries are taking initiatives to improve their existing healthcare systems by increasing healthcare investments…

Drivers: increasing demand for minimally invasive/non-invasive procedures

In recent years, the demand for minimally invasive procedures has witnessed a significant increase owing to the advantages offered by these procedures over traditional treatment procedures—fewer operative complications, shorter hospitalization, less pain, smaller & more cosmetic incisions, lower risk of infection, reduced post-operative care, and quicker recovery.

Minimally invasive procedures…

Major Growth Driving Factors:

The growth of this market is mainly driven by the growing number of medical vendors across European region, increasing adoption of patient-specific medical devices. Moreover, Growth in this market is primarily driven by the rising focus on preventive medical equipment maintenance, growth in associated equipment markets, adoption of innovative funding mechanisms, and the increasing purchase of refurbished medical equipment. However, the high initial…

Growth Driving Factors:

The market for apheresis is primarily driven by the rising prevalence of chronic diseases and the growing number of and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.

However, the high cost of apheresis…

Drivers: Growing focus on developing alternatives for animal testing models

Animal models are widely used in biomedical research for human-specific diseases. However, there are various cases that demonstrate that animal models cannot always be predictive for human drug response, like in the case of drug toxicology studies. This is because there are wide variations in the metabolism of drugs and toxins in humans as compared to animals, which makes it nearly impossible to study…